KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Short term Debt (2016 - 2025)

Historic Short term Debt for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $2.3 billion.

  • Bristol Myers Squibb's Short term Debt rose 1050.83% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 billion, marking a year-over-year increase of 1050.83%. This contributed to the annual value of $2.3 billion for FY2025, which is 1050.83% up from last year.
  • Per Bristol Myers Squibb's latest filing, its Short term Debt stood at $2.3 billion for Q4 2025, which was up 1050.83% from $4.5 billion recorded in Q3 2025.
  • Bristol Myers Squibb's Short term Debt's 5-year high stood at $7.5 billion during Q1 2022, with a 5-year trough of $1.1 billion in Q3 2024.
  • Its 5-year average for Short term Debt is $3.8 billion, with a median of $3.5 billion in 2024.
  • Per our database at Business Quant, Bristol Myers Squibb's Short term Debt skyrocketed by 32329.77% in 2022 and then tumbled by 8028.17% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Short term Debt stood at $4.9 billion in 2021, then dropped by 13.82% to $4.3 billion in 2022, then dropped by 26.85% to $3.1 billion in 2023, then tumbled by 34.4% to $2.0 billion in 2024, then increased by 10.51% to $2.3 billion in 2025.
  • Its Short term Debt was $2.3 billion in Q4 2025, compared to $4.5 billion in Q3 2025 and $4.7 billion in Q2 2025.